The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report.

导出 LinkOut

翻译打印收藏纠错

作者： Louise,Füessl ^[1] ; Lena,Kreuzer ^[2] ; Kajetan,Nierychlewski ^[3] ; Tobias,Seibt ^[4] ; Manfred Johannes,Stangl ^[1] ; Dionysios,Koliogiannis ^[5] ; Bruno,Meiser ^[5] ; Markus,Schwarz ^[1] ; Michael,Fischereder ^[4] ; Stephan,Kemmner ^[2]

作者单位： Transplant Center, University Hospital Munich, Ludwig-Maximilians-University (LMU), Munich, Germany. ^[1] Division of Nephrology, Department of Medicine IV, University Hospital Munich, Ludwig-Maximilians-University (LMU), Munich, Germany. ^[2] Department of Nephrology and Rheumatology, Augustinum Klinik München, Munich, Germany. ^[3] Institute of Laboratory Medicine, University Hospital Munich, Ludwig-Maximilians-University (LMU), Munich, Germany. ^[4] Department of General, Visceral and Transplantation Surgery, University Hospital Munich, Ludwig-Maximilians-University (LMU), Munich, Germany. ^[5]

关键词 calcineurin inhibitor toxicity extended-release tacrolimus kidney transplantation prolonged-release tacrolimus tacrolimus

DOI 10.3389/fmed.2024.1336035

PMID 38988355

发布时间 2024-07-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in medicine

2024年11卷

1336035页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report.

Frontiers in medicine

相似文献

Frontiers in medicine

相关期刊

检索历史清除